As doctors begin to see more and more patients with long-term impact from the COVID-19 virus (so called long-haulers), it’s important to consider what we know about similar viruses and use this evidence for treating patients who have contracted COVID-19 and are experiencing long-term brain disorders. It more than apparentRead
As COVID-19 continues to spread across the United States and vaccine distribution begins, the National Pharmacy Technician Association (NPTA), a provider of ACPE-accredited continuing education and advanced training programs for certified pharmacy technicians, is announcing the launch of a nationally-recognized vaccine pharmacy technician training program. Developed under the guidance ofRead
While it is understood that obesity is a risk factor for COVID-19 severity, there is new evidence that adipose tissue plays a key role in the aggravation of the virus and the development of a cytokine storm. One of the theories under investigation is that fat cells (adipocytes) act asRead
A nutraceutical study shows that chemical compounds in foods or beverages like green tea, muscadine grapes and dark chocolate can bind to and block protease function in SARS-CoV-2 virus, according to plant biologists at North Carolina State University. “One of our lab’s focuses is to find nutraceuticals in food orRead
During the height of the pandemic, researchers at Children’s National Hospital discovered that as many as one half of children with COVID-19 and multi-system inflammatory disease in children (MIS-C) at the hospital developed cardiac complications including coronary artery abnormalities, even when diagnosed and treated promptly. The data was shared asRead
A study involving more than 5,000 COVID-19 patients in Houston finds that the virus that causes the disease is accumulating genetic mutations, one of which may have made it more contagious. According to the paper published in the peer-reviewed journal mBIO, that mutation, called D614G, is located in the spikeRead
A new study by researchers at Icahn School of Medicine at Mount Sinai identifies different types of cardiac structural damage experienced by COVID-19 patients after myocardial injury that are associated with deadly conditions including heart attack, pulmonary embolism, heart failure, and myocarditis. These myocardial abnormalities are associated with higher riskRead
Although the lungs are a common target for COVID-19’s cytokine storm, so are the kidneys, making the 1-in-4 U.S. adults with diabetes resulting in diabetic kidney disease at increased risk for virus mortality. But why are the kidneys so attractive to the coronavirus? Recently published in Kidney International, a nationalRead
Certain oral antiseptics and mouthwashes may have the ability to inactivate human coronaviruses, according to a Penn State College of Medicine research study. The results indicate that some of these products might be useful for reducing the viral load, or amount of virus, in the mouth after infection and mayRead
Although most patients with COVID-19 present with respiratory symptoms, gastrointestinal (GI) symptoms have also been reported in up to 25% of patients with novel corona virus disease (COVID-19). Case reports show acute pancreatitis as an initial presentation in patients with COVID-19. Research shows that islet cells of the pancreas containRead
Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.
